Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Chibale

Showing results (281-290 of 315) with videos related to

Pageof 32
Sort By:
ACS Medicinal Chemistry Letters|December 18, 2024
Discovery of Non-Covalent Inhibitors for SARS-CoV-2 PLpro: Integrating Virtual Screening, Synthesis, and Experimental ValidationBruna K P Sousa, Melina Mottin, Donald Seanego, et al.
Journal of Medicinal Chemistry|April 19, 2018
Identification of Fast-Acting 2,6-Disubstituted Imidazopyridines That Are Efficacious in the in Vivo Humanized Plasmodium falciparum NODscidIL2Rγ <sup>null</sup> Mouse Model of MalariaAloysius T Nchinda, Claire Le Manach, Tanya Paquet, et al.
Journal of Medicinal Chemistry|November 30, 2012
Structure-activity relationship studies of orally active antimalarial 3,5-substituted 2-aminopyridinesDiego González Cabrera, Frederic Douelle, Yassir Younis, et al.
Journal of Medicinal Chemistry|January 23, 2014
2,4-Diaminothienopyrimidines as orally active antimalarial agentsDiego González Cabrera, Claire Le Manach, Frederic Douelle, et al.
Journal of Medicinal Chemistry|January 18, 2017
Antimalarial Pyrido[1,2-a]benzimidazoles: Lead Optimization, Parasite Life Cycle Stage Profile, Mechanistic Evaluation, Killing Kinetics, and in Vivo Oral Efficacy in a Mouse ModelKawaljit Singh, John Okombo, Christel Brunschwig, et al.
Journal of Medicinal Chemistry|November 10, 2015
Pyrrolo[3,4-c]pyridine-1,3(2H)-diones: A Novel Antimycobacterial Class Targeting Mycobacterial RespirationRenier van der Westhuyzen, Susan Winks, Colin R Wilson, et al.
Journal of Medicinal Chemistry|March 7, 2012
3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potentialYassir Younis, Frederic Douelle, Tzu-Shean Feng, et al.
Journal of Medicinal Chemistry|March 11, 2026
Examination of Coligands in Mefloquine-Metal Complexes Reveals the Structural Determinants of Activity against <i>Plasmodium falciparum</i> and <i>Schistosoma mansoni</i>Wilmer Villarreal, Helenita Costa Quadros, Legna Colina-Vegas, et al.
Journal of Medicinal Chemistry|August 14, 2025
Novel Inhibitors of <i>Plasmodium</i> Phosphatidylinositol 4-kinase IIIβ with Low Propensity for Resistance: Life Cycle Stage Activity and <i>In Vivo</i> Efficacy in a Humanized Mouse Malaria Infection ModelGodwin A Dziwornu, Mmakwena M Mmonwa, Dina Coertzen, et al.
ACS Infectious Diseases|August 14, 2024
The Tuberculosis Drug Candidate SQ109 and Its Analogs Have Multistage Activity against <i>Plasmodium falciparum</i>Savannah J Watson, Mariëtte E van der Watt, Anjo Theron, et al.
Pageof 32

Showing results (281-290 of 315) with videos related to

Sort By:
Pageof 32
ACS Medicinal Chemistry Letters|December 18, 2024
Discovery of Non-Covalent Inhibitors for SARS-CoV-2 PLpro: Integrating Virtual Screening, Synthesis, and Experimental ValidationBruna K P Sousa, Melina Mottin, Donald Seanego, et al.
Journal of Medicinal Chemistry|April 19, 2018
Identification of Fast-Acting 2,6-Disubstituted Imidazopyridines That Are Efficacious in the in Vivo Humanized Plasmodium falciparum NODscidIL2Rγ <sup>null</sup> Mouse Model of MalariaAloysius T Nchinda, Claire Le Manach, Tanya Paquet, et al.
Journal of Medicinal Chemistry|November 30, 2012
Structure-activity relationship studies of orally active antimalarial 3,5-substituted 2-aminopyridinesDiego González Cabrera, Frederic Douelle, Yassir Younis, et al.
Journal of Medicinal Chemistry|January 23, 2014
2,4-Diaminothienopyrimidines as orally active antimalarial agentsDiego González Cabrera, Claire Le Manach, Frederic Douelle, et al.
Journal of Medicinal Chemistry|January 18, 2017
Antimalarial Pyrido[1,2-a]benzimidazoles: Lead Optimization, Parasite Life Cycle Stage Profile, Mechanistic Evaluation, Killing Kinetics, and in Vivo Oral Efficacy in a Mouse ModelKawaljit Singh, John Okombo, Christel Brunschwig, et al.
Journal of Medicinal Chemistry|November 10, 2015
Pyrrolo[3,4-c]pyridine-1,3(2H)-diones: A Novel Antimycobacterial Class Targeting Mycobacterial RespirationRenier van der Westhuyzen, Susan Winks, Colin R Wilson, et al.
Journal of Medicinal Chemistry|March 7, 2012
3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potentialYassir Younis, Frederic Douelle, Tzu-Shean Feng, et al.
Journal of Medicinal Chemistry|March 11, 2026
Examination of Coligands in Mefloquine-Metal Complexes Reveals the Structural Determinants of Activity against <i>Plasmodium falciparum</i> and <i>Schistosoma mansoni</i>Wilmer Villarreal, Helenita Costa Quadros, Legna Colina-Vegas, et al.
Journal of Medicinal Chemistry|August 14, 2025
Novel Inhibitors of <i>Plasmodium</i> Phosphatidylinositol 4-kinase IIIβ with Low Propensity for Resistance: Life Cycle Stage Activity and <i>In Vivo</i> Efficacy in a Humanized Mouse Malaria Infection ModelGodwin A Dziwornu, Mmakwena M Mmonwa, Dina Coertzen, et al.
ACS Infectious Diseases|August 14, 2024
The Tuberculosis Drug Candidate SQ109 and Its Analogs Have Multistage Activity against <i>Plasmodium falciparum</i>Savannah J Watson, Mariëtte E van der Watt, Anjo Theron, et al.
Pageof 32